Japanese automaking giant Toyota has come up with a novel sidestep around the refueling stations that have proven to be a ...

AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

The first patient to undergo recently approved gene therapy for sickle cell disease, Kendric Cromer, has left the hospital.

Editas, one of the oldest CRISPR-focused biotechs, is pivoting again — to a sickle cell treatment that requires editing a ...

Hydrogen's popularity as a fuel option lies in the fact that the only byproduct of the power it generates is water.

Negasi Zuberi, 30, has gone by aliases Justin Kouassi, Justin Joshua Hyche and Sakima Zuberi, according to authorities.

A team of engineers at China's LONGi Central R&D Institute, working with colleagues from Shenzhen Campus of Sun Yat-sen ...

Carpenter is using AI and other computational methods to do exactly that, helping to propel an AI-driven boom in cell biology ...

Zuberi, 30, who federal prosecutors said had constructed a cell inside his garage in Klamath Falls, has been found guilty of ...

Kendric Cromer began treatment with Bluebird bio's sickle cell gene therapy in May. Physicians removed stem cells from his bone marrow and sent them to a facility where new, healthy hemoglobin genes ...